By GlobeNewswire, September 24, 2013, 01:32:00 PM EDT
Leiden, The Netherlands, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ:RNA) today
announced presentations at upcoming investor conferences.
Hans GCP Schikan, Chief Executive Officer, will present a
corporate overview at the BioCentury NewsMakers conference in
New York, NY on Friday, September 27th, at 10:30am ET and
will also participate on a Fireside Chat at the Leerink Rare
Disease Roundtable in New York, NY on Tuesday, October
2nd, at 8:00am ET. A live webcast of the BioCentury
presentation can be accessed through the Investor section of the
Prosensa corporate website at http://ir.prosensa.eu/events.cfm
and will be archived for 90 days.
About Prosensa Holding N.V.
Prosensa (NASDAQ:RNA) is a Dutch biotechnology
company engaged in the discovery and development of RNA-modulating
therapeutics for the treatment of genetic disorders. Its primary
focus is on rare neuromuscular and neurodegenerative disorders with
a large unmet medical need, including Duchenne muscular dystrophy,
myotonic dystrophy and Huntington's disease. www.prosensa.com
CONTACT: Prosensa Holding N.V.Celia Economides, Director IR & Corporate Communications
Phone: +1 917 941 9059
Source: Prosensa Holding N.V.